Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity

Adi Reches, Yael Ophir, Natan Stein, Inbal Kol, Batya Isaacson, Yoav Charpak Amikam, Afek Elnekave, Pinchas Tsukerman, Paola Kucan Brlic, Tihana Lenac, Barbara Seliger, Stipan Jonjic, Ofer Mandelboim*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity'. Together they form a unique fingerprint.

Medicine & Life Sciences